News

UM Researchers Land NIH Contract to Develop Opioid Addiction Vaccine

July 9, 2019/

Jay Evans-and-Gov Bullock-web

The University of Montana has received a $3.3 million contract from the National Institutes of Health to develop an innovative vaccine targeting opioid addiction.

The principal investigator on the two-year award is Dr. Jay Evans, director of UM’s Center for Translational Medicine and a research professor in the Division of Biological Sciences. Other investigators on the award are Drs. David Burkhart, Kendal Ryter and Helene Bazin-Lee from UM in Missoula, Marco Pravetoni from the University of Minnesota, and Paul Pentel and Mark LeSage from Hennepin Healthcare Research Institute.


Click here to read the story.

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


The Missoula Chamber of Commerce advances the quality of life in Missoula by advocating for a healthy, responsible & diverse business environment & by providing resources that help businesses succeed. Contact Sharon Morren, Director of Membership, [email protected] to join.

MATR Supporters (view all)


Working closely with GFDA’s economic development team, HPF helps Montana businesses access the capital they need to expand, modernize, and strengthen local communities.

ADROIT Employer Resources is a Montana-based workforce and talent solutions partner

The Great Falls Development Alliance delivers aggressive, award-winning economic development support for business attraction, expansion, and retention.